Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3819-3829. Date of Electronic Publication: 2024 May 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology SARS-CoV-2 variants

  • Source: Emerging infectious diseases [Emerg Infect Dis] 2024 Jul; Vol. 30 (7), pp. 1430-1433.Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155

Record details

×
Academic Journal

Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

  • Authors : Asante MA; Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Michelsen ME

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Immunization, Secondary*/Immunization, Secondary*/Immunization, Secondary*/methods

  • Source: BMC medicine [BMC Med] 2024 Jun 24; Vol. 22 (1), pp. 263. Date of Electronic Publication: 2024 Jun 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

×
Academic Journal

BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study.

  • Authors : Musa S; Institute for Public Health of the Federation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina; Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina. Electronic address: .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3467-3473. Date of Electronic Publication: 2024 Apr 21.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analysis of COVID-19 Vaccine Adverse Drug Reactions Reported Among Sultan Qaboos University Hospital Staff.

  • Authors : Al Busaidi BH; Department of Pharmacy, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman.; Al Riyami IM

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 May; Vol. 24 (2), pp. 216-220. Date of Electronic Publication: 2024 May 27.Publisher: Sultan Qaboos University Country of Publication: Oman NLM ID: 101519915 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cross-Reactive Antibody Responses to Coronaviruses Elicited by SARS-CoV-2 Infection or Vaccination.

  • Authors : Lee RSH; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Cheng SMS

Subjects: Cross Reactions*/Cross Reactions*/Cross Reactions*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 May; Vol. 18 (5), pp. e13309.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

×
Academic Journal

Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.

  • Authors : Jongkees MJ; Department of Internal Medicine, Section Infectious Diseases, and Department of Medical Microbiology and Infectious Diseases.; Tan NH

Subjects: Immunization, Secondary* ; HIV Infections*/HIV Infections*/HIV Infections*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: AIDS (London, England) [AIDS] 2024 Jul 15; Vol. 38 (9), pp. 1355-1365. Date of Electronic Publication: 2024 May 28.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Vaccine effectiveness in reducing COVID-19-related hospitalization after a risk-age-based mass vaccination program in a Chilean municipality: A comparison of observational study designs.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3851-3856. Date of Electronic Publication: 2024 May 15.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster.

  • Authors : Li J; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.; Gong L

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/immunology COVID-19 breakthrough infectionsSARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2024 Jul 11; Vol. 42 (18), pp. 3751-3755. Date of Electronic Publication: 2024 May 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI.

  • Authors : Ganelin-Cohen E; Neuroimmunological Clinic, Institute of Pediatric Neurology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subjects: Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/methods ; BNT162 Vaccine* ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/diagnostic imaging

  • Source: Brain and behavior [Brain Behav] 2024 Jul; Vol. 14 (7), pp. e3587.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101570837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  60,917 results for ""COVID-19 Vaccines""